Investors Contact Payment Careers Research Request Physician Portal
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Support
  • Lab
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request
  • Physician Portal

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Announces Reimbursement Expansion of ThyGeNEXT™

Sep 24, 2018

Interpace Diagnostics Supports Research Efforts of Pancreatic and Thyroid Cancer Patient Advocacy Groups

Sep 17, 2018

INTERPACE DIAGNOSTICS ANNOUNCES PARTICIPATION AT THE 20TH ANNUAL GLOBAL INVESTMENT CONFERENCE SPONSORED BY H.C.WAINWRIGHT & CO.

Aug 27, 2018

Interpace Diagnostics to Present at the 10th Annual Next Generation Dx Summit 2018

Aug 20, 2018

Interpace Diagnostics Acquires Select Assets of Rosetta Genomics Out of Bankruptcy

Aug 15, 2018

Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

Aug 9, 2018

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on Thursday, August 9, 2018

Aug 1, 2018

Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

Jul 31, 2018

Interpace Diagnostics Announces CIGNA’s Expansion of Coverage to Now Include ThyraMIR®

Jul 26, 2018

Interpace Diagnostics Expands Application of Pancreatic Cancer Test

Jul 19, 2018
    • 1...
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • ...24
    © 2025 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap Manage Cookie Preferences
    We Own Our Future Logo
    • Linkedin